Sean Rice Joins ClinEdge as Vice President of Site Operations
QUINCY, Mass., January 7, 2021 (Newswire.com) - ClinEdge, a leading clinical and trial management solutions provider to research sites, pharmaceutical companies, and CROs, announced today that Sean Rice joined the company as Vice President of Site Operations for the Research Site Network Division. This newly created role expands on ClinEdge's continued enhancements and commitment to the Site Network business line to provide end-to-end solutions to expedite the trial management process for all stakeholders while providing the best research sites to pharmaceutical trials across multiple therapeutic areas.
Sean will be responsible for overseeing all administrative and operational functions of the Site Network business line, including day-to-day management of study pipelines both at the sponsor and site level, improving site and sponsor portals, and supporting innovative site operations workflows within the ClinEdge business lines. Sean's role is a key contributor to building the Site Network business line's continued long-term value by applying experience, expertise, dedication, and creativity to solve site client needs and grow client relationships within the network.
Christian Burns, Co-CEO of ClinEdge, stated, "We are thrilled to welcome Sean to our innovative team at ClinEdge. He brings extensive experience in supporting research sites in building and scaling operations and revenues. As ClinEdge continues to be the fastest-growing resource for research sites offering access to the most competitive studies while providing sponsors and CROs a single-source solution for trial management with sites at the forefront, Sean's knowledge of the industry and understanding about research site operational innovations will enhance the expansion of the services we offer to better align the sites ability to conduct the right studies at the right times."
Sean brings over 10 years of research site operations and clinical trial technology solutions experience, most recently serving in a role focused on streamlining trial startup and enrollment to improve trial conduct. He developed strategies focused on leveraging technology to maximize workflow efficiencies at the site level to better align with CRO and Sponsor needs for more predictable site identification, selection, and mobilization.
Al Peters, Co-CEO of ClinEdge, added, "ClinEdge is focused on evolving and adding site business experts to lead new initiatives that support the delivery of improved, value-added trial solutions to our site partners with enhancements to our overall platform."
About ClinEdge
ClinEdge provides a full suite of clinical and outsourced business services to pharmaceutical companies, clinical research institutions, and CROs. The company includes a global network of research clinics, patient recruitment and retention, marketing and creative design engagement services, patient travel coordination, trial management, staffing, and financial service solutions. With extensive experience in medical indications representing all therapeutic areas and a specialty in rare disease engagement, the company has helped clients successfully conduct thousands of clinical studies by maximizing clinical research operations, minimizing enrollment times, and improving overall business performance. To learn more, visit www.clin-edge.com.
Source: ClinEdge